Catheter Precision (VTAK) Convertible Debt (2025)
Catheter Precision's (VTAK) quarterly Convertible Debt came in at $1.3 million in Q4 2025.
Catheter Precision (VTAK) Convertible Debt (2025) Analysis & Trends
Catheter Precision (VTAK) has 1 years of Convertible Debt data on file, last reported at $1.3 million in Q4 2025.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.3 million, changed N/A from the prior year.
- Convertible Debt for Q4 2025 stood at $1.3 million.
- Over the last five years, Convertible Debt for VTAK reached as high as $1.3 million in Q4 2025 and fell as low as $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Mn |